A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-c...

por LeCaer, H, Barlesi, F, Corre, R, Jullian, H, Bota, S, Falchero, L, Vergnenegre, A, Dujon, C, Delhoume, J Y, Chouaid, C
Publicado 2011

Clinical ACO phenotypes: Description of a heterogeneous entity

por Lainez, S., Court-Fortune, I., Vercherin, P., Falchero, L., Didi, T., Beynel, P., Piperno, D., Frappe, E., Froudarakis, M., Vergnon, J.M., Devouassoux, G.
Publicado 2019

509P COVID-19 disease among lung cancer (LC) patients: Data from a real-life prospective multicentric study

por Molinier, O., Falchero, L., Monnet, I., Decroisette, C., Neidhart, A-C., Redureau, E., Chiappa, A-M., Bigot, F., Bedossa, A., Amrane, K., Jeandeau, S., Dujon, C., Bugnet, A-S., Bonnefoy, P., Alizon, C., Meyer, N., Couraud, S., Cortot, A., Letierce, A., Debieuvre, D.
Publicado 2022